These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 82887)
21. Sera from patients with halothane hepatitis contain antibodies to halothane-induced liver antigens which are not detectable by immunoblotting. Knight TL; Scatchard KM; Van Pelt FN; Kenna JG J Pharmacol Exp Ther; 1994 Sep; 270(3):1325-33. PubMed ID: 7932186 [TBL] [Abstract][Full Text] [Related]
22. Halothane hepatitis 28 years after primary exposure. Martin JL; Dubbink DA; Plevak DJ; Peronne A; Taswell HF; Hay EJ; Pumford NR; Pohl LR Anesth Analg; 1992 Apr; 74(4):605-8. PubMed ID: 1554130 [No Abstract] [Full Text] [Related]
24. Lymphocyte cytotoxicity to halothane altered hepatocytes in patients with severe hepatic necrosis following halothane anaesthesia. Mieli-Vergani G; Vergani D; Tredger JM; Eddleston AL; Davis M; Williams R J Clin Lab Immunol; 1980 Jul; 4(1):49-51. PubMed ID: 7463474 [TBL] [Abstract][Full Text] [Related]
25. Drug metabolism and genetic polymorphism in subjects with previous halothane hepatitis. Ranek L; Dalhoff K; Poulsen HE; Brøsen K; Flachs H; Loft S; Wantzin P Scand J Gastroenterol; 1993 Aug; 28(8):677-80. PubMed ID: 8210981 [TBL] [Abstract][Full Text] [Related]
26. Lymphocyte transformation in halothane-related hepatitis. Moult PJ; Adjukiewicz AB; Gaylarde PM; Sarkany I; Sherlock S Br Med J; 1975 Apr; 2(5962):69-70. PubMed ID: 1131552 [No Abstract] [Full Text] [Related]
27. Halothane hepatitis: a series of case report following podiatric surgery. Giorgini RJ; Giorgini GL; Lombardo M J Foot Surg; 1982; 21(3):170-3. PubMed ID: 7119369 [No Abstract] [Full Text] [Related]
28. Sensitisation to halothane-altered liver components in severe hepatic necrosis after halothane anaesthesia. Vergani D; Tsantoulas D; Eddleston AL; Davis M; Williams R Lancet; 1978 Oct; 2(8094):801-3. PubMed ID: 81359 [TBL] [Abstract][Full Text] [Related]
34. The liver in mild halothane hepatitis. Light and electron microscopic findings with special reference to the mononuclear cell infiltrate. Uzunalimoglu B; Yardley JH; Boitnott JK Am J Pathol; 1970 Dec; 61(3):457-78. PubMed ID: 4115160 [No Abstract] [Full Text] [Related]
35. Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. Vergani D; Mieli-Vergani G; Alberti A; Neuberger J; Eddleston AL; Davis M; Williams R N Engl J Med; 1980 Jul; 303(2):66-71. PubMed ID: 6991940 [TBL] [Abstract][Full Text] [Related]
36. Neoantigens associated with halothane hepatitis. Pohl LR; Kenna JG; Satoh H; Christ D; Martin JL Drug Metab Rev; 1989; 20(2-4):203-17. PubMed ID: 2680380 [No Abstract] [Full Text] [Related]
37. Detection of autoantibodies directed against human hepatic endoplasmic reticulum in sera from patients with halothane-associated hepatitis. Kitteringham NR; Kenna JG; Park BK Br J Clin Pharmacol; 1995 Oct; 40(4):379-86. PubMed ID: 8554940 [TBL] [Abstract][Full Text] [Related]
38. Halothane hepatitis. Neuberger J; Williams R Dig Dis; 1988; 6(1):52-64. PubMed ID: 3349642 [TBL] [Abstract][Full Text] [Related]
39. Perspectives in the pathogenesis of halothane-induced hepatitis. Owen AD; van der Veen BW S Afr Med J; 1986 Jun; 69(13):807-10. PubMed ID: 3520883 [TBL] [Abstract][Full Text] [Related]